These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ligand-selective activation of mu-oid receptor: demonstrated with deletion and single amino acid mutations of third intracellular loop domain. Chaipatikul V, Loh HH, Law PY. J Pharmacol Exp Ther; 2003 Jun; 305(3):909-18. PubMed ID: 12626655 [Abstract] [Full Text] [Related]
6. Agonist-dependent mu-opioid receptor signaling can lead to heterologous desensitization. Chu J, Zheng H, Zhang Y, Loh HH, Law PY. Cell Signal; 2010 Apr; 22(4):684-96. PubMed ID: 20043990 [Abstract] [Full Text] [Related]
7. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine. Narita M, Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y, Suzuki T. Neuroscience; 2006 Apr; 138(2):609-19. PubMed ID: 16417975 [Abstract] [Full Text] [Related]
8. Receptor endocytosis counteracts the development of opioid tolerance. Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, Höllt V. Mol Pharmacol; 2005 Jan; 67(1):280-7. PubMed ID: 15475572 [Abstract] [Full Text] [Related]
9. Mu opioid receptor-effector coupling and trafficking in dorsal root ganglia neurons. Walwyn WM, Wei W, Xie CW, Chiu K, Kieffer BL, Evans CJ, Maidment NT. Neuroscience; 2006 Oct 13; 142(2):493-503. PubMed ID: 16887280 [Abstract] [Full Text] [Related]
10. Mu-opioid receptor desensitization in mature rat neurons: lack of interaction between DAMGO and morphine. Bailey CP, Couch D, Johnson E, Griffiths K, Kelly E, Henderson G. J Neurosci; 2003 Nov 19; 23(33):10515-20. PubMed ID: 14627635 [Abstract] [Full Text] [Related]
11. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation. Wang H, Guang W, Barbier E, Shapiro P, Wang JB. Neuroreport; 2007 Dec 03; 18(18):1969-73. PubMed ID: 18007196 [Abstract] [Full Text] [Related]
14. Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells. Doll C, Pöll F, Peuker K, Loktev A, Glück L, Schulz S. Br J Pharmacol; 2012 Nov 03; 167(6):1259-70. PubMed ID: 22725608 [Abstract] [Full Text] [Related]
15. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat. Narita M, Miyoshi K, Narita M, Suzuki T. Neuroscience; 2007 Feb 09; 144(3):777-82. PubMed ID: 17156932 [Abstract] [Full Text] [Related]
16. Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. El Kouhen R, Burd AL, Erickson-Herbrandson LJ, Chang CY, Law PY, Loh HH. J Biol Chem; 2001 Apr 20; 276(16):12774-80. PubMed ID: 11278523 [Abstract] [Full Text] [Related]
17. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor. Nowoczyn M, Marie N, Coulbault L, Hervault M, Davis A, Hanouz JL, Allouche S. Neuropharmacology; 2013 Oct 20; 73():368-79. PubMed ID: 23792280 [Abstract] [Full Text] [Related]
18. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid μ-opioid receptor desensitization. Miess E, Gondin AB, Yousuf A, Steinborn R, Mösslein N, Yang Y, Göldner M, Ruland JG, Bünemann M, Krasel C, Christie MJ, Halls ML, Schulz S, Canals M. Sci Signal; 2018 Jul 17; 11(539):. PubMed ID: 30018083 [Abstract] [Full Text] [Related]
19. Ligand-dependent spatiotemporal signaling profiles of the μ-opioid receptor are controlled by distinct protein-interaction networks. Civciristov S, Huang C, Liu B, Marquez EA, Gondin AB, Schittenhelm RB, Ellisdon AM, Canals M, Halls ML. J Biol Chem; 2019 Nov 01; 294(44):16198-16213. PubMed ID: 31515267 [Abstract] [Full Text] [Related]
20. Involvement of kappa opioid receptors in the inhibition of receptor desensitization and PKC activation induced by repeated morphine treatment. Hamabe W, Yamane H, Harada S, Tokuyama S. J Pharm Pharmacol; 2008 Sep 01; 60(9):1183-8. PubMed ID: 18718122 [Abstract] [Full Text] [Related] Page: [Next] [New Search]